Diseases of the Digestive System Completed Phase 2 / 3 Trials for Ketamine (DB01221)

IndicationStatusPhase
DBCOND0084019 (Diseases of the Digestive System)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02929524Intranasal Ketamine as a Sedative for VenipunctureTreatment